Blog Detail
 Lenacapavir Shortage Hits Four Nigerian States as Demand Rises

NaijaTalk

|

2026-09-26

Lenacapavir Shortage Hits Four Nigerian States as Demand Rises

# Lenacapavir Shortage Hits Four Nigerian States as Demand Rises Supplies of Lenacapavir, a long-acting injectable drug used to prevent HIV infection, have run out in several Nigerian states only months after the Federal Government began a pilot rollout of the new prevention option. Findings published by *Saturday PUNCH* on September 26, 2026, showed that Benue, Kwara, Gombe and Cross River have experienced stock-outs of the twice-yearly HIV prevention injection. The shortages have occurred amid growing demand for the drug, particularly among some people who prefer an injectable option to daily oral HIV pre-exposure prophylaxis, commonly known as PrEP.
However, the National Agency for the Control of AIDS has clarified that the shortages in the affected states should not be interpreted as a nationwide shortage of Lenacapavir. According to the agency, the current rollout is still a pilot programme, with logistics, distribution and funding challenges contributing to supply problems in individual states. Lenacapavir is a long-acting HIV pre-exposure prophylaxis medicine developed by Gilead Sciences.
Unlike daily oral PrEP, it is administered once every six months, providing eligible HIV-negative people with another option for reducing their risk of acquiring HIV. The World Health Organisation endorsed Lenacapavir as an additional HIV prevention option in July 2025. Nigeria received its first shipment of Lenacapavir in March 2026.
The Federal Government received 11,520 doses on March 19 and distributed the supply five days later to 10 pilot locations. The participating states and the Federal Capital Territory were Benue, Kwara, Akwa Ibom, Cross River, Gombe, Anambra, Ebonyi, Kano, Lagos and the FCT. The introduction of the drug was supported through the Global Fund and approved as part of Nigeria's efforts to expand HIV prevention options.
The National AIDS, Viral Hepatitis and STIs Control Programme said the long-acting injection could help people who find it difficult to consistently use daily oral HIV prevention medication. ### Benue Runs Out After Strong Uptake Benue State has recorded particularly strong demand since the drug was introduced. According to the state's Commissioner for Health and Human Services, Dr Paul Ogwuche, more than 2,000 HIV-negative people had received Lenacapavir since its introduction in May 2026.
Ogwuche confirmed that the state's initial allocation had been exhausted at participating health facilities. He described the situation as temporary and said the Federal Government was already processing additional supplies while the state was working with the relevant national programme and partners to facilitate replenishment. The commissioner also said some recipients had reported mostly mild side effects.
He explained that beneficiaries were counselled before receiving the injection and that suspected adverse reactions were being assessed and documented through established pharmacovigilance procedures. ### Kwara Awaits More Doses Kwara State has also exhausted its initial allocation. The state AIDS Programme Coordinator, Muhammed Rasheed, said more than 800 doses supplied during the initial
reference: https://punchng.com/morning-recap-sex-workers-scramble-as-anti-hiv-jab-runs-out-obi-momodu-condemn-el-rufais-prolonged-detention-other-top-stories/?utm_source=chatgpt.com

Subscribe To Get Updates on Our Latest Blog Post

No credit card required

0 Comments

No comments yet.

Leave Your Comment

You may also like

No related posts available